Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Artery Diseases | 1 | 2013 | 38 | 0.460 |
Why?
|
| Molecular Imaging | 1 | 2013 | 60 | 0.450 |
Why?
|
| Thiazolidines | 1 | 2011 | 6 | 0.400 |
Why?
|
| Histones | 1 | 2011 | 335 | 0.330 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 643 | 0.240 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 70 | 0.220 |
Why?
|
| Microdissection | 1 | 2022 | 24 | 0.210 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1300 | 0.210 |
Why?
|
| Macrophages | 2 | 2013 | 404 | 0.180 |
Why?
|
| Phosphorylation | 4 | 2019 | 613 | 0.170 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 42 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 87 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 57 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 208 | 0.160 |
Why?
|
| Thymus Gland | 1 | 2018 | 45 | 0.160 |
Why?
|
| Oligopeptides | 1 | 2018 | 95 | 0.160 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 171 | 0.150 |
Why?
|
| Parathyroidectomy | 1 | 2018 | 75 | 0.150 |
Why?
|
| Collagen | 1 | 2018 | 223 | 0.150 |
Why?
|
| Thyroidectomy | 1 | 2018 | 103 | 0.150 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 167 | 0.150 |
Why?
|
| Heptanoic Acids | 2 | 2013 | 39 | 0.140 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 196 | 0.140 |
Why?
|
| Pyrroles | 2 | 2013 | 78 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2019 | 249 | 0.140 |
Why?
|
| Mice | 6 | 2019 | 6428 | 0.140 |
Why?
|
| Microglia | 2 | 2013 | 137 | 0.130 |
Why?
|
| Lithium Chloride | 1 | 2013 | 6 | 0.120 |
Why?
|
| Ligation | 1 | 2013 | 64 | 0.120 |
Why?
|
| Cell Line | 2 | 2013 | 1152 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 62 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 60 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 44 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 34 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 176 | 0.110 |
Why?
|
| Monocytes | 1 | 2013 | 156 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 93 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 101 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1551 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2013 | 315 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 1322 | 0.100 |
Why?
|
| Animals | 6 | 2019 | 14409 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 150 | 0.100 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 78 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2013 | 927 | 0.100 |
Why?
|
| Glucose | 1 | 2013 | 366 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 108 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 509 | 0.090 |
Why?
|
| Apoptosis | 2 | 2019 | 1302 | 0.090 |
Why?
|
| DNA Repair | 1 | 2011 | 203 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2011 | 275 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1063 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1476 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 428 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1097 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2019 | 1737 | 0.060 |
Why?
|
| Calcium | 2 | 2018 | 434 | 0.060 |
Why?
|
| Antigens | 1 | 2022 | 53 | 0.050 |
Why?
|
| Epitopes | 1 | 2022 | 89 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 69 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2022 | 35 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2022 | 56 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2022 | 49 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1249 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 313 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 531 | 0.050 |
Why?
|
| Humans | 5 | 2022 | 54391 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2019 | 8 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2019 | 12 | 0.040 |
Why?
|
| Sumoylation | 1 | 2019 | 21 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 65 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2019 | 75 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 581 | 0.040 |
Why?
|
| Proline | 1 | 2018 | 31 | 0.040 |
Why?
|
| Female | 3 | 2019 | 28471 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 1752 | 0.040 |
Why?
|
| Colon | 1 | 2019 | 111 | 0.040 |
Why?
|
| Proteolysis | 1 | 2018 | 102 | 0.040 |
Why?
|
| Aorta | 1 | 2019 | 177 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 116 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 111 | 0.040 |
Why?
|
| Cell Movement | 1 | 2018 | 271 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 259 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 288 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2019 | 294 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 600 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 1504 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2018 | 328 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2013 | 34 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1647 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 87 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 99 | 0.030 |
Why?
|
| Pravastatin | 1 | 2012 | 16 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 112 | 0.030 |
Why?
|
| Simvastatin | 1 | 2012 | 35 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 2001 | 0.030 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2012 | 19 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 200 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 3419 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 13082 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 3049 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 14207 | 0.010 |
Why?
|
| Male | 1 | 2019 | 27347 | 0.010 |
Why?
|